Thrombosis & Thromboembolism 2022

Thrombosis & Thromboembolism 2022

Regular price
$20.00
Sale price
$20.00
Regular price
Sold out
Unit price
per 

Oakstone Thrombosis & Thromboembolism 2022

Format: 45 videos + 2 pdfs, size: 12.4 GB

Course Audience: physicians, nurse practitioners (NPs), and physician assistants (PAs) interested in changes and advances impacting the care of patients who have or are at risk for thrombotic disorders

Novel Targets for Atherosclerosis Prevention

What’s New with TG and AngPTL3 – Aruna D. Pradhan, MD, MPH, MSc

What’s New with Lp(a) – Samia Mora, MD

What’s New with LDL and ApoB – Jorge Plutzky, MD

What’s New with Inflammatory Targets – Paul M. Ridker, MD, MPH

Discussion/Q&A – John F. Keaney, Jr., MD – Moderator

Peripheral Arterial Disease

PAD – Pathways for Optimizing Cardiovascular and Limb Outcomes – Marc P. Bonaca, MD, MPH

Discussion/Q&A – Marie D. Gerhard-Herman, MD – Moderator

Heart Failure

Heart Failure and Venous Thromboembolism – Samuel Z. Goldhaber, MD

More Than Just Diabetes and Heart Failure – SGLT2 – Deepak L. Bhatt, MD, MPH

More Than Just Diabetes and Heart Failure – GLP1 – Brendan M. Everett, MD, MPH

Heart Failure – Reduced Ejection Fraction – Marc A. Pfeffer, MD, PhD

Discussion/Q&A – Akshay Suvas Desai, MD, MPH – Moderator

Heart Failure – Preserved Ejection Fraction – Scott D. Solomon, PhD

Heart Failure – Middle-of-the-Road Ejection Fraction – Navigating the Alphabet Soup – Michele A. Hamilton, MD

CMR Imaging of Imaging of Heart Failure – Raymond Y. Kwong, MD, MPH

Atrial Fibrillation & Coronary Disease

Dual Antiplatelet Therapy and Anticoagulation – Michelle L. O’Donoghue, MD, MPH

How to Manage the Anticoagulation Around Ablation and Cardioversions and Watchmans for AF – Bruce A. Koplan, MD

Anticoagulation

Dose-Reduced Direct Oral Anticoagulants – Efficacy and Safety – Behnood Bikdeli, MD, MS

Duration of Anticoagulation – Arterial Thrombosis – Navigating Limitations in Data and Variations in Practice – Teresa Carman, MD, RPVI, MSVM

Duration of Anticoagulation – Venous Thrombosis – Gregory Piazza, MD, MS

Novel Anticoagulation Targets – Factor XI and XII Inhibitors – Jeffrey I. Weitz, MD, FRCPC, FACP, FRSC, FCCP, FACC, FESC, FCAHS, FAHA, FSVM, FCCS

Discussion/Q&A – Samuel Z. Goldhaber, MD – Moderator

Racial Disparities in Arterial and Venous Thrombosis

Racial Disparities in Healthcare – Cassandra M. Pierre, MD, MSc, MPH

Racial Disparities in Arterial and Venous Thrombosis – Karlyn A. Martin, MD, MS

Discussion/Q&A – Gregory Piazza, MD, MS – Moderator

Genetics

VTE Prediction – Using Genetics as a Powerful Tool – Nicholas A. Marston, MD, MPH

Clonal Hematopoiesis of Indeterminate Potential (CHIP) – Association with VTE & PAD – Peter Libby, MD

Discussion/Q&A – Gregory Piazza, MD, MS – Moderator

Covid and Thrombosis

COVID and Thrombosis – Mechanisms and Epidemiology – Gregory Piazza, MD, MS

Prevention of VTE in COVID-19 Patients – Behnood Bikdeli, MD, MS

Discussion/Q&A – Samuel Z. Goldhaber, MD – Moderator

VTE Prevention

VTE Prophylaxis for Orthopedic Surgery – Samuel Z. Goldhaber, MD

Discussion/Q&A – Ebrahim Barkoudah, MD, MPH – Moderator

PE Reperfusion

Device Therapy for PE Reperfusion – Navigating a Rapidly Changing Landscape – Gregory Piazza, MD, MS

Systemic Fibrinolysis (PEITHO-3) – Samuel Z. Goldhaber, MD

Adventures with Hypertrophic Cardiomyopathy – 1958-2022 – Eugene Braunwald, MD

Pulmonary Hypertension and Thrombosis

Chronic Thromboembolic Pulmonary Hypertension – Bradley A. Maron, MD

Pulmonary Hypertension After PE That is Not Chronic Thromboembolic Pulmonary Hypertension – Jane A. Leopold, MD, FACC, FAHA, FSCAI

Post-Thrombotic Syndrome

Post-thrombotic Syndrome – Epidemiology and Medical Therapy – Susan R. Kahn, MD, MSc, FRCPC, ABIM

Intervention, Acute Intervention, and Chronic Venous Obstructive Disease – Suresh Vedantham, MD

Discussion/Q&A – Arvind K. Pandey, MD – Moderator

VTE and Cancer

Vascular Cardio-Oncology – Javid Moslehi, MD

Prevention of Thrombotic Complications of Cancer and Cancer Therapy – Simon Mantha, MD, MPH

Treatment of Cancer-Associated Thrombosis – Michael B. Streiff, MD

Discussion/Q&A – Jean Connors, MD – Moderator